Evaluation of the Zetiq Histological and Cytological Staining Technique for the Detection Cervical Cancer
Phase 1
18 Years
75 Years
18 Years
75 Years
Not Enrolling
Female
Cervical Cancer
Female
Cervical Cancer
Trial Information
Evaluation of the Zetiq Histological and Cytological Staining Technique for the Detection Cervical Cancer
Inclusion Criteria:
1. FEMALE SUBJECT BETWEEN 18 AND 75 YEARS OF AGE.
2. ABILITY TO PROVIDE INFORMED CONSENT
Exclusion Criteria:
1. SUBJECT WITH KNOWN PREGNANCY AT TIME OF SCREENING.
2. PREVIOUS HISTORY OF HYSTERECTOMY
3. PARTICIPATION IN ANOTHER CLINICAL TRIAL WITHIN LAST 30 DAYS.
Type of Study:
Observational
Study Design:
Time Perspective: Prospective
Principal Investigator
Ami Fishman, Prof
Investigator Role:
Principal Investigator
Investigator Affiliation:
Meir medical Center, affiliated with Sackler School of Medicine, Tel-Aviv University
Authority:
Israel: The Israel National Institute for Health Policy Research and Health Services Research
Study ID:
ZT-CL-01A
NCT ID:
NCT01584414
Start Date:
October 2007
Completion Date:
April 2010
Related Keywords:
- Cervical Cancer
- Zetiq CellDetect ® stain
- distinct red/purple color to the cytoplasm of neoplastic
- distinguishes green/blue stained non-neoplastic cells and tissues
- Uterine Cervical Neoplasms
Name | Location |
|---|
